Teva Seeks To Revoke Astellas' Incontinence Drug Patent
Israeli generics giant Teva Pharmaceuticals has sued Astellas Pharma in England, seeking to invalidate the Japanese drugmaker's patent for treating urinary concerns....To view the full article, register now.
Already a subscriber? Click here to view full article